Analysis of the Efficacy of Therapeutic Complex in Patients of Gastroenterological Profile with Candidiasis of the Mucous Membrane of the Upper Digestive Tract

I.V. Kushnirenko

Abstract


The problem of the treatment for candidiasis of mucosa of the upper digestive tract remains relevant because of the need of both a causal treatment, and taking into account the variability of the immune response in the interaction of the microorganism and Candida albicans. Reduced immunoreactivity in this case requires the corrective treatment. The objective — to study the effect of therapeutic complex with an inclusion of polypeptide immunomodulator imunofan on the performance of innate and adaptive immunity in patients of this group. According to the findings, patients with invasion of fungi in the mucosa are characterized by the presence of immune deficiency in terms of the ratio of white blood cells/CD3+, which is 1.3 times higher than in patients with oropharyngeal and superficial candidiasis (p < 0.01). After the treatment in the group of patients with Candida invasion of mucosa, the initially increased value of HCT test and cytochemical index of neutrophil activity were decreased by 40.40 % (p < 0.05) and 29.03 % (p < 0.05), respectively. These changes, along with increased levels of circulating immune complexes by 1.4 times compared with the values before treatment (p < 0.05) and 1.5 times — compared to controls (p < 0.01), indicate a deeper defects of the innate immunity, which obviously lead to a more severe course of disease and the difficulty in treatment. In general, the use of medical complex leads to the recovery of T-cell immunity in both groups of patients, with normalization of the T-helper/T-suppressors ratio, to an increase in the level of lactoferrin in the oral cavity and the increased concentration of IgA and IgG in patients with invasion. Therefore, a comprehensive approach to the treatment of patients with mucosal candidiasis of the upper gastrointestinal tract and determining the strategy and tactics of further observations are necessary for the effective provision of care.


Keywords


candidiasis; mucosa; immunity; treatment; efficacy

References


Ohshima T., Kojima Y., Seneviratne C. J. Therapeutic Applicationof Synbiotics, a Fusion of Probiotics and Prebiotics, and Biogenics as a New Concept for Oral Candida Infections: A Mini Review. Frontiers in Microbiology, 2016, Vol. 7, Article 10.

Delsing C. E., Bleeker-Rovers C. P., Kullberg B. J. Treatment of candidiasis: insights from host genetics. Expert Rev. Anti Infect. Ther., 2012, Aug; 10 (8), pp. 947–956.

Pinegin B. W., Latycheva T. W. Imunodeficitnie sostoiania: vozmozhnisti primenenia imunomoduliatorov [Immunodeficiency states: the possibility of using immunomodulators]. Lechashy vrach [The Doctor], 2001, № 03. Available at: http://www.lvrach.ru/2001/03/4528628. (In Russ.)

Simonova A. V, Lebedeva I. S. Innovatsionnie metodi diagnostiki i lechenia vtorichnykh imunodefizitnykh sostoianiy [Innovative methods of diagnosis and treatment of secondary immunodeficiencies]. Lechashy vrach [The Doctor], 2012, № 4. Available at: http://www.lvrach.ru/2012/04/15435391. (In Russ.)

Trunova L. A., Yanova I. V., Efremov A. V. Perspektyvy reabilitazii chronicheskykh infekzionno-vospalitelnykh zabolevaniy, vizivaemikh opportunisticheskoy microfloroy [Prospects of the rehabilitation of chronic infectious and inflammatory diseases caused by opportunistic microflora]. Systemnye producty zdorovia osnova profilaktiki, reabilitazii i povychenia kachestva zhizni: matirialy mezhdunarodnoy nauchn.-praktich. konf. [System products of the health as the basis of prevention, rehabilitation for increase of quality of life: materials of the intern. scientific-pract. conf], М., 2003, pp. 220–235. (In Russ.)

Kushnirenko I.V. Osoblovosti imunnoi reaktivnosti u pazientov is kandidozom slizovoi obolonki verchniogo viddilu travnogo tractu pri raznoi glibini ii urazhennia [Features of immune reactivity in patients with mucosal candidiasis of the upper part of gastrointestinal tract at different depths of lesions]. Bucovinsky medichnii visnik [The medical journal of Bucovina], 2011, № 2 (58), pp. 222 – 225. (In Ukr.)

Mosiychuk L. M., Kushnirenko I. V., Tatarchukh О. M.. Osoblovosti klitinnogo i gumoralnogo imunitetu u pazientiv is kandidozom slizovoi obolonki verchniogo viddilu chlunkovo-kichkovogo tractu [Features of the cells and humoral immunity in patients with mucosal candidiasis of the upper part of gastrointestinal tract]. Gastroenterologiya [Gastroenterology], 2011, Vol. 45, pp. 110–119. (In Ukr.)

Kushnirenko I. V., Tatarchuk О. M., Egorova S.Yu. Miszeviy imunitet ta adgesivni vlastivosti Candida albicans u khvorikh is zapalnimi ta erosivno-viraskovimi zakhvoruvanniami verkhniogo viddilu shlunkovo-kishkovogo tractu [Local immunity and adhesive properties of Candida albicans in patients with inflammatory and erosive-ulcerative diseases of the upper part of gastrointestinal tract]. Ukrainskiy medichnii almanakh [Ukrainian medical almanakh], 2013, Т. 16, № 2, pp. 126–128. (In Ukr.)

Lebedev V. V., Pokrovsky V. I., Shelepova T. M., Stepanov O.G. Sredstvo dlia lechenia imunodefizitnikh sostoianiy [The agent for the treatment of immunodeficiency states]. Patent RF, no. 2062096, 1996. (In Russ.)

P. G. Pappas, C. A. Kauffman, D. R. Andes. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis., 2015, published online.

Zwolinska-Wcislo M., Brzozowski T., Mach T. Are probiotics effective in the treatment of fungal colonization of the gastrointestinal tract? Experimental and clinical studies. Journal of physiology and pharmacology, 2006, 57, Suppl. 9, pp. 35–49.

Manzoni P. Use of Lactobacillus casei subspecies Rhamnosus GG and gastrointestinal colonization by Candida species in preterm neonates. J. Pediatr. Gastroenterol. Nutr., 2007, Dec; 45, Suppl 3, pp. 190–194.

Murzyn A., Krasowska A., Stefanowicz P. Capric acid secreted by S. boulardii inhibits C. albicans filamentous growth, adhesion and biofilm formation. PLoS One, 2010, 5 (8), e12050.

Kumar S., Bansal A., Chakrabarti A. Evaluation of efficacy of probiotics in prevention of candida colonization in a PICU-a randomized controlled trial. Crit. Care Med., 2013, 41 (2), pp. 565–572.

Matsubara V. H., Bandara H. M. H. N., Mayer M. P.A. Probiotics as antifungals in mucosal candidiasis. Clinical Infectious Diseases Dis., 2016, May 1; 62 (9), pp.1143–1153.

Park B. H., Fikrig S. M., Smithwich E. M. Infection and nitroblue tetrazolium reduction by neutrophils. Lancet, 1968, Vol. 2, pp. 532–534.

Vasilzov M. К., Shymkevich E. М. Trudy nauchnoy konf. aspirantov i ordinatorov [Proceedings of the Scientific Conference for graduate students and interns], М. : Мир, 1964, pp. 18–20. (In Russ.)

Haskova V., Xaslik K. L., Rina F. Simple method of ciculating immune complex cloteetion in human polyethilen glicol precipitation. G. Immunitete farsch., 1978, Vol. 154, № 4, pp. 399–406.

Petri А., Sebin К. Naglyadnaya statistika v medicine [Transparent statistics in medicine], М.: Geotar-med, 2003, 143 p. (In Russ.)

Fletcher R., Fletcher S., Vagner E. Klinicheskaya epidemiologia: osnovi dokazatelnoi mediciny [Clinical epidemiology: the basis of evidence-based medicine], М.: Media Sfera, 2004, 347 p.




DOI: https://doi.org/10.22141/2308-2097.3.61.2016.79155

Refbacks

  • There are currently no refbacks.


Copyright (c) 2016 GASTROENTEROLOGY

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2017

 

 Яндекс.МетрикаSeo анализ сайта Рейтинг@Mail.ru